Buparlisib
| Catalog Number | Pack Size | List Price* | Quantity | |
|---|---|---|---|---|
| HY-70063-5MG | 5 mg | 105,00 | Add | |
| HY-70063-1ML | 10mM/1mL | 114,00 | Add | |
| HY-70063-10MG | 10 mg | 150,00 | Add | |
| HY-70063-50MG | 50 mg | 196,00 | Add | |
| HY-70063-100MG | 100 mg | 241,00 | Add | |
| HY-70063-200MG | 200 mg | 393,00 | Add | |
| HY-70063-500MG | 500 mg | 697,00 | Add | |
| HY-70063-S-1ST | Sample | Inquire |
* CHF, excl. 8.1% VAT and shipping costs
Product Description
Best price guarantee – we offer you the lowest price in Switzerland. Please contact us for a quote if needed.
Buparlisib (BKM120; NVP-BKM120) is a pan-class I PI3K inhibitor, with IC50s of 52, 166, 116 and 262 nM for p110α, p110β, p110δ and p110γ, respectively.
| Category | Biochemicals |
| Supplier | MedChem Express |
| Regulatory Status | RUO |
| Research Field | Cancer, Apoptosis,PI3K/Akt/mTOR |
| Format | Solubility: DMSO : 100 mg/mL (ultrasonic);H2O : < 0.1 mg/mL (ultrasonic;warming;heat to 60°C) |
| Grade | Clinical information: Phase 3 |
| Purity | 99.9% |
| Molecular Formula | C18H21F3N6O2 |
| Molecular Weight | 410.39 |
| CAS-Number | 944396-07-0 |
| Storage Conditions | -20°C, 3 years; 4°C, 2 years (Powder) |
| Tech. Data Sheet | View datasheet |
| Link To Supplier | http://www.medchemexpress.com |
| Shipping Details | Room Temperature |
| Material Safety Data Sheet | Download PDF |
